Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Organisation › Details

Progenika Biopharma S.A.

Progenika Biopharma SA is a biotechnology company specialised in personalized medicine that develops DNA biochips for the diagnosis, prognosis and prediction of response to treatment human diseases. Progenika offers a series of tools for molecular diagnosis in areas such as: inmunohematology, familial hypercholesterolemia, nervous system disorders, and treatment optimization. In addition to BLOODchip, other leading products include LIPOchip, PHARMAchip, and Promonitor. Progenika was founded in 2000 and has development and production centres in Bizkaia Technology Park (Spain), Medford (Massachusetts, USA) and Mexico D.F. Its products are marketed in America, Europe and the Middle East. *

 

Period Start 2000-04-01 established
  Group Grifols (Group)
Product Industry DNA microarray technology
     
Region Region Spain_oo
  Country Spain (España)
  Street Parque Tecnológico de Bizkaia, Building 801B
  City 48160 Derio-Vizcaya
  Tel +34-944-064-525
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2010-09-28)
     
    * Document for �About Section�: Grifols S.A.. (3/4/13). "Press Release: Grifols Acquires 60% of the Capital of Spanish Biotechnology Firm Progenika Biopharma". Barcelona.
     
   
Record changed: 2017-11-20

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Grifols (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81




» top